window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 17, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

synthetic biology

  • Biotech & Pharma Business,Therapeutic Areas

    Biotech and psychedelics converge: Psylink CEO Laura Korsakova on reshaping mental health at Baltic Life Sciences

    Speaking at Baltic Life Sciences, Laura Korsakova, co-founder and CEO [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Strand lands $153M to advance programmable mRNA cancer therapies

    Boston-based Strand Therapeutics has raised $153 million in a Series [...]

    May 5, 2026
  • Advanced Therapies,Digital & Data,Drug Discovery & Development

    Elegen and Nutcracker pilot cell-free RNA manufacturing for personalized cancer therapeutics

    Collaboration targets faster, lower-cost production of RNA-based therapies with reduced [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development

    Broken String and BioLizard partner on AI tool to improve gene editing safety

    Eurostars-3 grant supports development of SafeGuide to reduce time and [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Biostate AI raises $12M to build the ‘Netflix’ of molecular diagnostics using RNAseq and GenAI

    Biostate AI has raised $12 million in Series A funding [...]

    May 5, 2026
  • Advanced Therapies

    GeneFab and RegCell partner to advance autoimmune Treg therapy toward US trials

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development

    Molecular Devices unveils automated QPix FLEX system to transform microbial colony picking

    New benchtop platform boosts speed, sterility, and accuracy for microbiology [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Context reports 29% response rate for CTIM-76 in platinum-resistant ovarian cancer
    Categories: Advanced Therapies, Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • VIVEbiotech expands in vivo lentiviral vector portfolio to 15 programmes
    Categories: Advanced Therapies, Biotech & Pharma Business, Manufacturing & Supply Chain
  • Oryzon reports strong early AML response data from iadademstat combinations at EHA 2026
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top